Linezolid and vancomycin for nosocomial infections in pediatric patients: a systematic review

CONCLUSION: Both linezolid and vancomycin showed good efficacy in the treatment of bacterial infections caused by resistant Gram-positive bacteria in hospitalized children. However, linezolid stands out regarding its pharmacological safety. Importantly, to strengthen this conclusion, further clinical trials are needed to provide additional evidence.PMID:38145631 | DOI:10.1016/j.jped.2023.08.011

Source: Jornal de Pediatria - December 25, 2023 Category: Pediatrics Authors: Bruno Russo Porchera Carolina Moraes da Silva Rayssa Pinheiro Miranda Ant ônio Rafael Quadros Gomes Pedro Henrique Dos Santos Fernandes Camili Giseli Oliveira de Menezes Paula do Socorro de Oliveira da Costa Laurindo Maria Fani Dolabela Heliton Patrick C Source Type: research